Schedule 13D ownership disclosure
Elicio Therapeutics, Inc.
Common Stock, par value $0.01 per share · CUSIP: 28657F103
Event date: 2025-03-05
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Yekaterina ChudnovskyReported CIK 0001979324
Shares: 9,657,539 · Class: 48.1%
- GKCC, LLCReported CIK 0001977769
Shares: 9,648,914 · Class: 48%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-035497
- Form type
- SCHEDULE 13D/A
- Filer
- Chudnovsky Yekaterina
- CIK
- CIK 1979324
- Filed
- Mar 07, 2025
- Reporting period
- Mar 05, 2025
- Description
- Schedule 13D beneficial ownership